Results
8
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
8 companies
Pharma Mar
Market Cap: €1.6b
A biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.
PHM
€90.10
7D
1.9%
1Y
212.6%
Parlem Telecom Companyia de Telecomunicacions
Market Cap: €64.6m
Parlem Telecom Companyia de Telecomunicacions, S.A.
PAR
€3.30
7D
0.6%
1Y
-10.6%
Labiana Health
Market Cap: €22.2m
Develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.
LAB
€3.18
7D
3.2%
1Y
98.8%
Oryzon Genomics
Market Cap: €224.5m
A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.
ORY
€3.23
7D
13.8%
1Y
83.0%
Soltec Power Holdings
Market Cap: €145.3m
Engages in the development of solutions for photovoltaic energy projects in Spain, Italy, Brazil, the United States, Mexico, Argentina, Chile, Colombia, Peru, Panama, Australia, China, India, Thailand, France, Denmark, Egypt, Israel, Portugal, the United Arab Emirates, Romania, and Kenya.
SOL
€1.60
7D
0%
1Y
-52.6%
Facephi Biometria
Market Cap: €55.0m
Engages in the biometric facial recognition technology solutions in Spain and internationally.
FACE
€2.28
7D
-2.1%
1Y
8.6%
Adolfo Domínguez
Market Cap: €44.3m
Engages in the design, manufacture, acquisition, sale, marketing, retail, import, and export of ready-made garments, footwear, handbags and accessories, household linen, furniture, and decorative objects.
ADZ
€4.80
7D
-2.6%
1Y
9.1%
Promotora de Informaciones
Market Cap: €541.8m
Engages in the exploitation of media in Spain and internationally.
PRS
€0.47
7D
18.1%
1Y
28.8%